Kamada secures $22M extension of Canadian supply tender (NASDAQ:KMDA)
seekingalpha.com
news
2022-10-19 11:26:17

Oct. 19, 2022 7:26 AM ETKamada Ltd. (KMDA)By: Meghavi Singh, SA News Editor Kamada (NASDAQ:KMDA) was awarded an extension of an existing tender from the Canadian Blood Services (CBS) for the supply of four IgG products, CYTOGAM速, HEPAGAM速, VARIZIG速 and WINRHO速 SDF, for an additional three years for an approximate total value of $22M. The award secures the ongoing sales of those products in the Canadian market. The four commercial products, approved by Health Canada and the U.S. Food and Drug Administration were acquired by Kamada in November 2021.
